Evolution Summit 2021 | Marcus Evans Group | 8 December 2021 | The Ritz-Carlton, 4012 Central Florida Pkwy, Orlando, FL 32837, USA

At marcus evans, the well-being of our clients and employees is our top priority and we are committed to doing everything in our power to keep our summits safe and successful. For this reason, we are taking the necessary steps to minimise risk and enhance safety for our attendees and staff.

The Evolution Summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

2021 Speakers

Kenneth Getz
Director, Research Professor, Tufts Center for the Study of Drug Development

Harry Leider, MD, MBA
Chief Medical Officer and EVP, Gelesis, Inc.

Daniel Selness
Executive Director, Clinical and Technical Operations, Mitsubishi Tanabe Pharma Development America

Jennifer Lee
VP, Clinical Operations and Data Management, Elevar Therapeutics

Len Rosenberg, PhD, RPh
Head, Clinical Operations, Leukemia & Lymphoma Society

Camisha Harge
VP, Clinical Operations, Aslan Pharmaceuticals

T.J. Sharpe
Patient Advocate

Yadenis Jimenez
Site Director, VICIS Clinical Research

Robert Leon
General Manager, Bayside Medical Group

Lorena Gomez
Senior Director, Global Study Start Up, PRO Management and Digital Implementation, AbbVie

Bruce Morimoto
Vice President, Drug Development, Cerecin

Pamela Perry
VP, Clinical Operations and Quality Management, Cerevel Therapeutics, LLC

Harry Leider, MD, MBA
Chief Medical Officer and EVP, Gelesis, Inc.

LaShell Robinson
Director, Diversity & Inclusion in Clinical Trials, Takeda Pharmaceutical Company

Angie V. Sánchez, MD, MPH
Assistant Director, MGH CARE Research Center, Harvard Medical School

Deborah Braccia, PhD, MPA
Head, Global Medical Affairs Excellence, Kyowa Kirin, Inc.

Craig Conoscenti
Executive Director/Therapeutic Area Head, Respiratory IPF/ILD, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals

Juliana Ison
Research Program Coordinator, MGH CARE Research Center, Harvard Medical School

Alice Drumheller
VP, Clinical Operations, Sensei Biotherapeutics

Dr Deven V. Parmar MD, FCP
Chief Medical Officer and Head, Clinical R&D, Zydus Therapeutics Inc

DYNAMIC MODERATOR:

Craig Conoscenti
Executive Director/Therapeutic Area Head, Respiratory IPF/ILD, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals

2021 Partners

MEDIA PARTNERS:
• Drug Discover Today
• Clinical Trials
• Pharma Voice